A Randomized, Controlled Trial of Intranasal Oxytocin as an Adjunct to Behavioral Therapy for Autism Spectrum Disorder
Abstract
The primary objectives of this clinical study are test the two hypotheses that (1) cognitive behavioral therapy (CBT) aimed at core social dysfunctions and (2) oxytocin (OT) administration prior to CBT sessions will each enhance social function in young adults with autism spectrum disorders (ASD). A third objective is to examine whether neuroimaging measures of brain function and structure can predict CBT treatment responsiveness.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2013
- Accession Number
- ADA604189
Entities
People
- John Gabrieli
Organizations
- Massachusetts General Hospital